Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it.
Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it.
复制标题
DOI：
10.1111/add.15290
复制
发表时间：
2021-07
期刊：
影响因子：
--
通讯作者：
McClure EA
中科院分区：
文献类型：
--
作者：
Hindocha C;McClure EA
大麻-烟草共同使用的全国代表性数据表明，这些物质被密切地包围，并具有显著的不良健康后果，尽管共同使用的人口一级危害在很大程度上是未知的。目前的流行病学研究并未以产生必要数据来得出有关健康影响的结论的方式评估共同使用。这就产生了一个隐藏的共同使用者群体，他们得不到充分的服务。因此，本文有两个目的：1）审查由于大麻和尼古丁产品法规的快速变化而导致的共同使用数据收集方面的新挑战，以及2）为共同使用的术语和评估提供建议。我们认为：1）在人口水平上，共同使用的普遍性没有得到准确评估，2）合法化的变化带来了新的挑战，但如果没有适当的监测，对共同使用的影响将无法被发现。我们提出了一套三层的共同使用评估建议，其中包括对大麻、烟草和共同使用指标的评估，范围从最小负担（共同管理产品的自我报告）到最大负担（检测、事件级数据）。我们建议临床研究开始纳入大麻-烟草共同使用评估，以更好地证明将其纳入临床试验和国家监测调查。合并共同使用评估将有助于了解不断变化的大麻和烟草/尼古丁监管环境对共同使用的真正影响。共同使用是普遍的和有问题的，并作出结论的能力，其健康结果是阻碍了缺乏细微差别的数据收集。如果你不衡量它，你就无法管理它。
Nationally representative data of cannabis-tobacco co-use have shown these substances are closely entwined and have significant adverse health consequences, though population-level harms of co-use are largely unknown. Current epidemiological research does not assess co-use in a manner that has yielded the necessary data to draw conclusions regarding health effects. This has given rise to a hidden population of co-users who go under-served. Therefore, this paper has two aims: 1) to review new challenges in the collection of co-use data due to rapidly changing regulations of cannabis and nicotine products, and 2) to provide recommendations for the terminology and assessment of co-use. We argue that: 1) the prevalence of co-use is not being assessed accurately at a population level and 2) changes in legalisation have created novel challenges, but without proper monitoring, the impact on co-use will go undetected. We propose a three-level tiered set of recommendations for co-use assessments, which includes assessments of cannabis, tobacco, and co-use metrics ranging from least burdensome (self-report of co-administered products) to most burdensome (assays, event-level data). We propose that clinical studies begin to incorporate cannabis-tobacco co-use assessments to justify better their inclusion in clinical trials and national surveillance surveys. Integration of co-use assessments will aid in understanding the true impact on co-use of the changing cannabis and tobacco/nicotine regulatory environments. Co-use is prevalent and problematic and the ability to make conclusions about its health outcomes is hindered by lack of nuance in data collection. If you don’t measure it, you can’t manage it.
登录
查看更多内容
影响因子：
4.2
作者：
Cerda, Magdalena;Sarvet, Aaron L.;Hasin, Deborah S.
通讯作者：
Hasin, Deborah S.
影响因子：
2.9
作者：
Fix, Brian Vincent;Smith, Danielle;Fong, Geoffrey
通讯作者：
Fong, Geoffrey
DOI：
10.1111/j.1360-0443.2012.03837.x
发表时间：
2012-07
期刊：
Addiction (Abingdon, England)
影响因子：
--
作者：
Agrawal A;Budney AJ;Lynskey MT
通讯作者：
Lynskey MT
影响因子：
12.7
作者：
Goodwin, Renee D.;Pacek, Lauren R.;Hasin, Deborah S.
通讯作者：
Hasin, Deborah S.
影响因子：
3.7
作者：
Cohn, Amy M.;Johnson, Amanda L.;Villanti, Andrea C.
通讯作者：
Villanti, Andrea C.